-
1
-
-
58149339930
-
Media calcification and intima calcification are distinct entities in chronic kidney disease
-
Amann K.: Media calcification and intima calcification are distinct entities in chronic kidney disease. Clin. J. Am. Soc. Nephrol., 2008, 6, 1599-1605.
-
(2008)
Clin. J. Am. Soc. Nephrol
, vol.6
, pp. 1599-1605
-
-
Amann, K.1
-
2
-
-
33645880441
-
Long-term comparison of sevelamer hydrochloride to calcium containing phosphate binders
-
Brewster U.C., Ciampi M.A., Abu-Alfa A.K.: Long-term comparison of sevelamer hydrochloride to calcium containing phosphate binders. Nephrology (Carlton), 2006, 11, 142-146.
-
(2006)
Nephrology (Carlton)
, vol.11
, pp. 142-146
-
-
Brewster, U.C.1
Ciampi, M.A.2
Abu-Alfa, A.K.3
-
3
-
-
58049213889
-
Location of acute coronary artery thrombses in patients with and without chronic kidney disease
-
Charytan D.M., Kuntz R.E., Garshick M.: Location of acute coronary artery thrombses in patients with and without chronic kidney disease. Kidney. Int., 2009, 75, 1, 80-87.
-
(2009)
Kidney. Int
, vol.75
, Issue.1
, pp. 80-87
-
-
Charytan, D.M.1
Kuntz, R.E.2
Garshick, M.3
-
4
-
-
0036310682
-
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
-
Chertow G.M., Burke S.K., Raggi P.: Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney. Int., 2002, 62, 245-252.
-
(2002)
Kidney. Int
, vol.62
, pp. 245-252
-
-
Chertow, G.M.1
Burke, S.K.2
Raggi, P.3
-
5
-
-
31044455712
-
Paricalcitol capsule for the treatment of secondary hyperparathyroisism in stages 3 and 4 CKD
-
Coyne D.W., Acharaya M., Qin P.: Paricalcitol capsule for the treatment of secondary hyperparathyroisism in stages 3 and 4 CKD. Am. J. Kidney. Dis., 2006, 47, 263-276.
-
(2006)
Am. J. Kidney. Dis
, vol.47
, pp. 263-276
-
-
Coyne, D.W.1
Acharaya, M.2
Qin, P.3
-
7
-
-
53749105878
-
Consistent control of mineral and bone disorder in incident hemodialysis patients
-
Denese M.D., Belozeroff V., Smirnakis K.: Consistent control of mineral and bone disorder in incident hemodialysis patients. Clin. J. Am. Soc. Nephrol., 2008, 3(5), 1423-1429.
-
(2008)
Clin. J. Am. Soc. Nephrol
, vol.3
, Issue.5
, pp. 1423-1429
-
-
Denese, M.D.1
Belozeroff, V.2
Smirnakis, K.3
-
8
-
-
0033624518
-
Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2) therapy for secondary hyperparathyroidism
-
Frazao J.M., Elangovan L., Maung H.M.: Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2) therapy for secondary hyperparathyroidism. Am. J. Kidney. Dis. 2000, 36, 3, 550-561.
-
(2000)
Am. J. Kidney. Dis
, vol.36
, Issue.3
, pp. 550-561
-
-
Frazao, J.M.1
Elangovan, L.2
Maung, H.M.3
-
9
-
-
85206956135
-
-
Giachelli C.M: The emerging role of phosphate in vascular calcification. Kidney.Int., 2009. (epub ahead of print).
-
Giachelli C.M: The emerging role of phosphate in vascular calcification. Kidney.Int., 2009. (epub ahead of print).
-
-
-
-
10
-
-
0034682247
-
Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis
-
Goodman W.G., Goldin J., Kuizon B.D.: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl. J. Med., 2000, 342, 1478-1483.
-
(2000)
N Engl. J. Med
, vol.342
, pp. 1478-1483
-
-
Goodman, W.G.1
Goldin, J.2
Kuizon, B.D.3
-
11
-
-
52449118724
-
Long term efficacy and safety profile of lanthanum carbonate: Results for up to 6 years of treatment
-
Hutchinson A.J., Barnett M.E., Krause R.: Long term efficacy and safety profile of lanthanum carbonate: results for up to 6 years of treatment. Nephron. Clin. Pract., 2008, 110, c15-c23.
-
(2008)
Nephron. Clin. Pract
, vol.110
-
-
Hutchinson, A.J.1
Barnett, M.E.2
Krause, R.3
-
12
-
-
77949427864
-
-
Isakova T., Gutierrez O.M., Chang Y.: Phosphorus binders and survival on hemodialysis J. Am.Soc. Nephrol., 2008, 17, epub. ahead of print.
-
Isakova T., Gutierrez O.M., Chang Y.: Phosphorus binders and survival on hemodialysis J. Am.Soc. Nephrol., 2008, 17, epub. ahead of print.
-
-
-
-
13
-
-
48249147434
-
Treatment o chronic kidney disease-mineral and bone disorder (CKD-MBD)
-
Komaba H., Tanaka M., Fukagawa M.: Treatment o chronic kidney disease-mineral and bone disorder (CKD-MBD) Intern. Med., 2008, 989-994.
-
(2008)
Intern. Med
, pp. 989-994
-
-
Komaba, H.1
Tanaka, M.2
Fukagawa, M.3
-
14
-
-
38749153987
-
Battelground: Chronic kidney disorders mineral and bone disease-calcium obsession, vitamin D, and binder confusion
-
Kovesdy C.P., Mehrotra R., Kalantar-Zadeh K.: Battelground: chronic kidney disorders mineral and bone disease-calcium obsession, vitamin D, and binder confusion. Clin. J. Am. Soc. Nephrol., 2008, 3, 168-173.
-
(2008)
Clin. J. Am. Soc. Nephrol
, vol.3
, pp. 168-173
-
-
Kovesdy, C.P.1
Mehrotra, R.2
Kalantar-Zadeh, K.3
-
15
-
-
58449107131
-
3, arterial calcifications and cardiovascular risk markers in hemodialysis patients
-
3, arterial calcifications and cardiovascular risk markers in hemodialysis patients, Nephrol. Dial. Transplant., 2009, 24, 2, 611-618.
-
(2009)
Nephrol. Dial. Transplant
, vol.24
, Issue.2
, pp. 611-618
-
-
Matias, P.J.1
Ferreira, C.2
Jorge, C.3
-
16
-
-
58149352649
-
Accelerated atherosclerotic calcification and Mönckeberg's sclerosis: A continuum of advanced vascular pathology in chronic kidney disease
-
McCullough P.A., Agrawal V., Danielewicz E.: Accelerated atherosclerotic calcification and Mönckeberg's sclerosis: a continuum of advanced vascular pathology in chronic kidney disease. Clin. J. Am. Soc. Nephrol., 2008, 3, 1585-1598.
-
(2008)
Clin. J. Am. Soc. Nephrol
, vol.3
, pp. 1585-1598
-
-
McCullough, P.A.1
Agrawal, V.2
Danielewicz, E.3
-
17
-
-
38749101028
-
The OPTIMA study: Assessing a new cinacalcet (sensipar/mimpara) treatment algorithmfor secondary hyperparathyroidism
-
Messa P., Macario F., Yaqoob M.: The OPTIMA study: assessing a new cinacalcet (sensipar/mimpara) treatment algorithmfor secondary hyperparathyroidism. Clin. J. Am. Soc. Nephrol., 2008, 3, 36-45.
-
(2008)
Clin. J. Am. Soc. Nephrol
, vol.3
, pp. 36-45
-
-
Messa, P.1
Macario, F.2
Yaqoob, M.3
-
18
-
-
33645757920
-
Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
-
Moe S., Drfjeke T., Cunningham J.: Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney. Int., 2006, 1945-1953.
-
(2006)
Kidney. Int
, pp. 1945-1953
-
-
Moe, S.1
Drfjeke, T.2
Cunningham, J.3
-
19
-
-
58149374010
-
Improving global outcomes in mineral and bone disorders
-
Moe S., Drüeke T.: Improving global outcomes in mineral and bone disorders. Clin. J. Am. Soc. Nephrol., 2008, 3, 127-130.
-
(2008)
Clin. J. Am. Soc. Nephrol
, vol.3
, pp. 127-130
-
-
Moe, S.1
Drüeke, T.2
-
20
-
-
34547121836
-
The case against calcium-based phosphate binders
-
Moe S.M., Chertow G.M.: The case against calcium-based phosphate binders. Clin J. Am. Soc. Nephrol., 2006, 1, 697-703.
-
(2006)
Clin J. Am. Soc. Nephrol
, vol.1
, pp. 697-703
-
-
Moe, S.M.1
Chertow, G.M.2
-
21
-
-
77949481605
-
Zalecenia Grupy Roboczej Zespohi Krajowego Konsultanta Medycznego w Dziedzinie Nefrologii dotycza̧ce rozpoznawania i leczenia zaburzeń gospodarki wapniowo-fosforanowej u pacjentów z przewleka̧ choroba̧ nerek
-
Nowicki M., Rutkowski B., Czekalski S.: Zalecenia Grupy Roboczej Zespohi Krajowego Konsultanta Medycznego w Dziedzinie Nefrologii dotycza̧ce rozpoznawania i leczenia zaburzeń gospodarki wapniowo-fosforanowej u pacjentów z przewleka̧ choroba̧ nerek. Nefrol. Dial. Pol., 2007, 11, 45-52.
-
(2007)
Nefrol. Dial. Pol
, vol.11
, pp. 45-52
-
-
Nowicki, M.1
Rutkowski, B.2
Czekalski, S.3
-
22
-
-
38449117963
-
-
Ann. Intern. Med, 18, 147, 12
-
Palmer S.C., McGregor D.O., Macaskill P.: Meta-analysis: vitamin D compounds in chronic kidney disease. Ann. Intern. Med., 2007, 18, 147, 12, 840-853.
-
(2007)
Meta-analysis: Vitamin D compounds in chronic kidney disease
, pp. 840-853
-
-
Palmer, S.C.1
McGregor, D.O.2
Macaskill, P.3
-
23
-
-
43849094954
-
A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: The Calcium Acetate Renagel Evaluation-2 (CARE-2) study
-
Qunibi W., Moustafa M., Bernardo M.: A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study. Am. J. Kidney Dis., 2008, 51, 6, 1022-1023.
-
(2008)
Am. J. Kidney Dis
, vol.51
, Issue.6
, pp. 1022-1023
-
-
Qunibi, W.1
Moustafa, M.2
Bernardo, M.3
-
24
-
-
58049208295
-
Vascular calcifications, vertebral fractures and mortality in haemodialysis patients
-
Rodriguez-Garcia M., Gomez-Alonso C., Naves-Diaz M. i wsp.: Vascular calcifications, vertebral fractures and mortality in haemodialysis patients. Nephrol. Dial. Transplant., 2009, 24, 1, 239-246.
-
(2009)
Nephrol. Dial. Transplant
, vol.24
, Issue.1
, pp. 239-246
-
-
Rodriguez-Garcia, M.1
Gomez-Alonso, C.2
Naves-Diaz, M.3
-
25
-
-
4043158681
-
Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor- κB ligand in Mönckenberg's sclerosis and atherosclerosis
-
Schoppet M., Al-Fakhiri N., Franke F.E.: Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor- κB ligand in Mönckenberg's sclerosis and atherosclerosis J. Clin. Endocrinol. Metab., 2004, 89(9), 4104-4112.
-
(2004)
J. Clin. Endocrinol. Metab
, vol.89
, Issue.9
, pp. 4104-4112
-
-
Schoppet, M.1
Al-Fakhiri, N.2
Franke, F.E.3
-
26
-
-
54949147219
-
Matrix Gla protein: The calcification inhibitor in need of vitamin K
-
Schurgers L.J., Cranenburg E.C., Vermeer C.: Matrix Gla protein: the calcification inhibitor in need of vitamin K. Thromb. Haemost 2008, 100, 4, 593-603.
-
(2008)
Thromb. Haemost
, vol.100
, Issue.4
, pp. 593-603
-
-
Schurgers, L.J.1
Cranenburg, E.C.2
Vermeer, C.3
-
27
-
-
33947303700
-
The vascular biology of calcification
-
Shroff R.C., Shanahan C.M.: The vascular biology of calcification. Semin. Dial., 2007, 2, 103-109.
-
(2007)
Semin. Dial
, vol.2
, pp. 103-109
-
-
Shroff, R.C.1
Shanahan, C.M.2
-
28
-
-
0037378444
-
Parikalcitol versus calcitriol therapy in the treatment of secondary hyperparathyroidism
-
Sprague S.M., Llach F., Amdahl M.: Parikalcitol versus calcitriol therapy in the treatment of secondary hyperparathyroidism. Kidney Int., 2003, 63, 1483-1490.
-
(2003)
Kidney Int
, vol.63
, pp. 1483-1490
-
-
Sprague, S.M.1
Llach, F.2
Amdahl, M.3
-
29
-
-
39449117385
-
A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and mortality in hemodialysis: A secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data
-
St Peter W.L., Liu J., Weinhandl E.: A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and mortality in hemodialysis: a secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data. Am. J. Kidney Dis., 2008, 51, 3, 445-454.
-
(2008)
Am. J. Kidney Dis
, vol.51
, Issue.3
, pp. 445-454
-
-
St Peter, W.L.1
Liu, J.2
Weinhandl, E.3
-
30
-
-
0042343804
-
Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy
-
Teng M., Wolf M., Lowrie E.: Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N. Engl. J. Med., 2003, 349, 446-456.
-
(2003)
N. Engl. J. Med
, vol.349
, pp. 446-456
-
-
Teng, M.1
Wolf, M.2
Lowrie, E.3
|